Cullinan Therapeutics, Inc. Common Stock CGEM
$16.87
-22.15%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 8-K | 8-K | 2026-09-24 | View → |
| 8-K | 8-K | 2026-09-14 | View → |
| 4 | 4 | 2026-09-10 | View → |
| 4 | 4 | 2026-08-14 | View → |
| 8-K | 8-K | 2026-08-13 | View → |
| 10-Q | 10-Q | 2026-08-06 | View → |
| 8-K | 8-K | 2026-08-06 | View → |
| 4 | 4 | 2026-07-07 | View → |
| 4 | 4 | 2026-07-02 | View → |
| 4 | 4 | 2026-07-02 | View → |
| 4 | 4 | 2026-06-18 | View → |
| 4 | 4 | 2026-06-18 | View → |
| 4 | 4 | 2026-06-18 | View → |
| 4 | 4 | 2026-06-18 | View → |
| 4 | 4 | 2026-06-18 | View → |
| 4 | 4 | 2026-06-18 | View → |
| 8-K | 8-K | 2026-06-16 | View → |
| 8-K | 8-K | 2026-06-10 | View → |
| 8-K | 8-K | 2026-06-08 | View → |
| 8-K | 8-K | 2026-05-18 | View → |
| 10-Q | 10-Q | 2026-05-07 | View → |
| 8-K | 8-K | 2026-05-07 | View → |
| 4 | 4 | 2026-05-06 | View → |
| DEF 14A | DEF 14A | 2026-04-28 | View → |
| 10-K | 10-K | 2026-03-10 | View → |
| 8-K | 8-K | 2026-03-10 | View → |
| 4 | 4 | 2026-03-09 | View → |
| 4 | 4 | 2026-02-26 | View → |
| 4 | 4 | 2026-02-25 | View → |
| 4 | 4 | 2026-02-25 | View → |
| 4 | 4 | 2026-02-25 | View → |
| 4 | 4 | 2026-02-25 | View → |
| 4 | 4 | 2026-02-23 | View → |
| 4 | 4 | 2026-02-23 | View → |
| 4 | 4 | 2026-02-23 | View → |
| 4 | 4 | 2026-02-23 | View → |
| 4 | 4 | 2026-02-23 | View → |
| 4 | 4 | 2026-02-19 | View → |
| 4 | 4 | 2026-02-19 | View → |
| 4 | 4 | 2026-02-19 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $16.87
- Market Cap
- $1.39 billion
- 52-Week Range
- $5.68 – $23.19
- Average Volume
- 951K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.